| Application no. and date | 98907434.9 (espacenet) (Federated) (European Patent Register), 19980206 | | Patent/reg. no. and date | DK/EP 1003474, 20090415 | | Publication date | 20000531 | | Priority no. and date | US 797472, 19970206 | | EP pub. no. and date |
EP 1003474 20000531 | | Effective date | | | Applicant/owner | Merck Sharp & Dohme Corp., 126 East Lincoln Avenue
Rahway, New Jersey 07065, US | | Applicant ref. no. | 136269 | | Inventor | RIDEOUT, Janet, L., 3101 Morningside Drive
Raleigh, NC 27607, US,
JACOBUS, Karla, M., 200 Riverwalk Circle
Cary, NC 27511, US,
PENDERGAST, William, 5815 Williamsburg Way
Durham, NC 27713, US,
YERXA, Benjamin, R., 1330 Hathaway Road
Raleigh, NC 27608, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 9/00 (2006.01) | | Title | Fremgangsmåde til behandling af tør øjensygdom med purinergiske receptoragonister | | Int. application no. | US1998002701 | | Int. publication no. | WO1998034593 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
